COMP <GO>
SGRY vs BKD // PIOTROSKI F-SCORE QUALITY
Surgery Partners Inc. (NASDAQ) VS. Brookdale Senior Living Inc. (NYSE) • 15-METRIC TALLY: SGRY 9
— BKD 1
▲ PIOTROSKI F-SCORE QUALITY LEADER: SGRY
LAST: $23.21 (-0.13%) • MKT CAP: $3.04B
piotroski-score
8/9
LAST: $10.27 (+2.91%) • MKT CAP: $2.45B
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SGRY VS. BKD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SGRY | BKD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 26.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 0.30% | +9.60 | SGRY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.7x | 34.6x | -24.90 | SGRY | /valuation <GO> |
| Free Cash Flow Yield | 6.44% | 0.67% | +5.77 | SGRY | /fcf-yield <GO> |
| Operating Margin | 45.80% | 0.40% | +45.40 | SGRY | /operating-margins <GO> |
| Net Profit Margin | -9.20% | -8.20% | -1.00 | BKD | /net-margins <GO> |
| Revenue Growth (YoY) | 6.60% | 2.20% | +4.40 | SGRY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.67 | 0.20 | +0.47 | SGRY | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 4/9 | +4.00 | SGRY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 86.2 | 46.0 | +40.20 | SGRY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.04B | $2.45B | $586.0M | SGRY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SGRY REV | BKD REV | SGRY GROSS % | BKD GROSS % | SGRY FCF | BKD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $3.19B | — | 26.2% | $195.6M | $16.5M |
| FY 2024 | $0 | $3.13B | — | 25.6% | $209.7M | -$35.1M |
| FY 2023 | $0 | $3.02B | — | — | $293.8M | $162.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SGRY // BETA 0.99
BKD // BETA —